The emerging approach of the medication represents a significant advance in the care of type 2 diabetes. Unlike existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide224836.tkzblog.com/41768145/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment